HALO vs. HROW
Compare and contrast key facts about Halozyme Therapeutics, Inc. (HALO) and Harrow Health, Inc. (HROW).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: HALO or HROW.
Correlation
The correlation between HALO and HROW is 0.11, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
HALO vs. HROW - Performance Comparison
Key characteristics
HALO:
1.23
HROW:
1.63
HALO:
1.77
HROW:
3.07
HALO:
1.28
HROW:
1.37
HALO:
1.33
HROW:
1.51
HALO:
3.82
HROW:
6.17
HALO:
12.70%
HROW:
22.69%
HALO:
39.49%
HROW:
85.65%
HALO:
-74.26%
HROW:
-99.46%
HALO:
-8.18%
HROW:
-79.65%
Fundamentals
HALO:
$7.11B
HROW:
$981.54M
HALO:
$3.43
HROW:
-$0.95
HALO:
$1.02B
HROW:
$132.78M
HALO:
$820.38M
HROW:
$97.67M
HALO:
$646.55M
HROW:
$2.55M
Returns By Period
In the year-to-date period, HALO achieves a 23.72% return, which is significantly higher than HROW's -16.30% return. Over the past 10 years, HALO has outperformed HROW with an annualized return of 14.23%, while HROW has yielded a comparatively lower 13.50% annualized return.
HALO
23.72%
4.84%
-7.36%
43.88%
23.63%
14.23%
HROW
-16.30%
-11.39%
-30.60%
156.44%
37.90%
13.50%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
HALO vs. HROW — Risk-Adjusted Performance Rank
HALO
HROW
HALO vs. HROW - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Halozyme Therapeutics, Inc. (HALO) and Harrow Health, Inc. (HROW). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
HALO vs. HROW - Dividend Comparison
Neither HALO nor HROW has paid dividends to shareholders.
Drawdowns
HALO vs. HROW - Drawdown Comparison
The maximum HALO drawdown since its inception was -74.26%, smaller than the maximum HROW drawdown of -99.46%. Use the drawdown chart below to compare losses from any high point for HALO and HROW. For additional features, visit the drawdowns tool.
Volatility
HALO vs. HROW - Volatility Comparison
The current volatility for Halozyme Therapeutics, Inc. (HALO) is 4.40%, while Harrow Health, Inc. (HROW) has a volatility of 14.10%. This indicates that HALO experiences smaller price fluctuations and is considered to be less risky than HROW based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
HALO vs. HROW - Financials Comparison
This section allows you to compare key financial metrics between Halozyme Therapeutics, Inc. and Harrow Health, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities